Pathology & Lab Medicine CME
-
Risk Stratification in Hematologic Malignancies
-
NCCN – MedscapeCME Oncology Renal Cell Carcinoma Tumor Board
-
NCCN-Medscape Oncology Breast Cancer Tumor Board
-
Defining the Role and Benefit of Oral Therapy in Metastatic Breast Cancer
-
Ongoing Challenges in Hepatitis B: Addressing Real-World Issues
-
Prevention of Late-Onset CMV Disease in Solid Organ Transplant Recipients
-
Exploring the Role of Adjuvant Therapy in GIST: Are We There Yet?
Medical Education Content
- PARP Inhibitors and Triple-Negative Breast Cancer
- Preventable Disease and Genomic Analysis: An Expert Interview With George H. Sack, MD, PhD
- Surgical Options for Massive Breast Enlargement in the Metastatic Setting
- T4b Tumors: What Comes First -- Neoadjuvant Systemic Therapy or Primary Surgery?
- Assessing the Risk for Development of Heart Disease -- The Role of Genetics: An Expert Interview With John P. Kane, MS, MD, PhD
Advisory Board
- Kathryn Foucar, MD, FASCP
- William A. Gardner, MD, FASCP
- Wayne W. Grody, MD, PhD, FASCP
- Denise Harmening, PhD, MT(ASCP), CLS(NCA)
- William R. Hart, MD, FASCP
- George D. Lundberg, MD, FASCP
- Robert W. McKenna, MD, FASCP
Scientific Director